Antineutrophil Cytoplasmic Antibodies, Autoimmune Neutropenia, and Vasculitis

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 3, 2011, Pages 424-433

  Grayson, Peter C ^a   Sloan, J Mark ^a   Niles, John L ^b   Monach, Paul A ^a   Merkel, Peter A ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antineutrophil cytoplasmic antibody (ANCA); Neutropenia; Vasculitis

Indexed keywords

GLUCOCORTICOID; METHOTREXATE; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ANCA ASSOCIATED VASCULITIS; ANTIBODY SPECIFICITY; ARTHRALGIA; ARTHRITIS; ARTICLE; AUTOIMMUNE NEUTROPENIA; BONE MARROW BIOPSY; CASE REPORT; DISEASE ASSOCIATION; DRUG MEGADOSE; EPIDIDYMITIS; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MALE; NEUTROPENIA; NEUTROPHIL CHEMOTAXIS; PERCEPTION DEAFNESS; PRIORITY JOURNAL; RASH; RECURRENT FEVER; SKIN BIOPSY;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA;

EID: 82955221881     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.02.003     Document Type: Article

References (45)

1. Capsoni F., Sarzi-Puttini P., Zanella A. Primary and secondary autoimmune neutropenia. Arthritis Res Ther 2005, 7(5):208-214.
2. Niles J.L. Antineutrophil cytoplasmic antibodies in the classification of vasculitis. Annu Rev Med 1996, 47:303-313.
3. Davoren A., Curtis B.R., Shulman I.A., Mohrbacher A.F., Bux J., Kwiatkowska B.J., et al. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion 2003, 43(5):641-645.
4. Stone J.H., Merkel P.A., Spiera R., Seo P., Langford C.A., Hoffman G.S., et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010, 363(3):221-232.
5. Bhatt V., Saleem A. Review: drug-induced neutropenia-pathophysiology, clinical features, and management. Ann Clin Lab Sci 2004, 34(2):131-137.
6. Sera N., Ashizawa K., Ando T., Abe Y., Ide A., Usa T., et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid 2000, 10(7):595-599.
7. Akamizu T., Ozaki S., Hiratani H., Uesugi H., Sobajima J., Hataya Y., et al. Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity. Clin Exp Immunol 2002, 127(1):92-98.
8. Yamada A., Sato K., Hara M., Tochimoto A., Takagi S., Hizuka N., et al. Propylthiouracil-induced lupus-like syndrome developing in a Graves' patient with a sibling with systemic lupus erythematosus. Intern Med 2002, 41(12):1204-1208.
9. Ozkok A., Salman S., Agan M., Yavuz A.S., Yarman S., Boztepe H., et al. Propylthiouracil induced anti-neutrophil cytoplasmic antibody-associated vasculitis with bone marrow plasmacytosis and granulocytopenia. Chin Med J (Engl) 2009, 122(9):1112-1114.
10. Farah R.E., Shay M.D. Symmetrical peripheral gangrene and neutropenia following propylthiouracil. Ann Pharmacother 2006, 40(6):1211.
11. Kawachi Y., Nukaga H., Hoshino M., Iwata M., Otsuka F. ANCA-associated vasculitis and lupus-like syndrome caused by methimazole. Clin Exp Dermatol 1995, 20(4):345-347.
12. Ahmed F., Kelsey P.R., Shariff N. Lupus syndrome with neutropenia following minocycline therapy-a case report. Int J Lab Hematol 2008, 30(6):543-545.
13. Sangala N., Lee R.W., Horsfield C., Goldsmith D.J. Combined ANCA-associated vasculitis and lupus syndrome following prolonged use of hydralazine: a timely reminder of an old foe. Int Urol Nephrol 2010, 42(2):503-506.
14. Rongioletti F., Ghio L., Ginevri F., Bleidl D., Rinaldi S., Edefonti A., et al. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 1999, 140(5):948-951.
15. Knowles L., Buxton J.A., Skuridina N., Achebe I., Legatt D., Fan S., et al. Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduct J 2009, 6:30.
16. Walsh N.M., Green P.J., Burlingame R.W., Pasternak S., Hanly J.G. Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol 2010, 37(12):1212-1219.
17. Bradford M., Rosenberg B., Moreno J., Dumyati G. Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med 2010, 152(11):758-759.
18. Czuchlewski D.R., Brackney M., Ewers C., Manna J., Fekrazad M.H., Martinez A., et al. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol 2010, 133(3):466-472.
19. Zhu N.Y., Legatt D.F., Turner A.R. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med 2009, 150(4):287-289.
20. Barbano G., Ginevri F., Ghiggeri G.M., Gusmano R. Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome. Pediatr Nephrol 1999, 13(7):602-603.
21. Juby A., Johnston C., Davis P., Russell A.S. Antinuclear and antineutrophil cytoplasmic antibodies (ANCA) in the sera of patients with Felty's syndrome. Br J Rheumatol 1992, 31(3):185-188.
22. Coremans I.E., Hagen E.C., van der Voort E.A., van der Woude F.J., Daha M.R., Breedveld F.C. Autoantibodies to neutrophil cytoplasmic enzymes in Felty's syndrome. Clin Exp Rheumatol 1993, 11(3):255-262.
23. Campion G., Maddison P.J., Goulding N., James I., Ahern M.J., Watt I., et al. The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. Medicine (Baltimore) 1990, 69(2):69-80.
24. Wehbe A.M., Johannsson B., Raife T.J., Bleile M., Bell A., Curtis B.R., et al. Severe autoimmune neutropenia associated with acute autoimmune hepatitis. Int J Hematol 2010, 91(4):673-678.
25. Cuadrado A., Aresti S., Cortes M.A., Gomez-Ortega J.M., Salcines J.R. Autoimmune hepatitis and agranulocytosis. Dig Liver Dis 2009, 41(7):e14-e16.
26. Hanawa N.T., Fukami M., Miura R., Goto H., Tashiro H., et al. Autoimmune neutropenia due to antineutrophil antibodies in a patient with primary sclerosing cholangitis. Clin J Gastroenterol 2010, 3:149-154.
27. Coppo P., Ghez D., Fuentes V., Bengoufa D., Oksenhendler E., Tribout B., et al. Antineutrophil cytoplasmic antibody-associated neutropenia. Eur J Intern Med 2004, 15(7):451-459.
28. Krishnan K., Ross C.W., Bockenstedt P.L., Adams P.T. Successful treatment of autoimmune neutropenia with recombinant human granulocyte-colony stimulating factor (R-metHuG-CSF). Clin Lab Haematol 1997, 19(2):105-109.
29. Rodrigues C.E., Velloso E.R., Pereira R.M., Bonfa E., Teixeira F.K., Bueno C., et al. A novel 60kDa reactivity in cyclic neutropenia: High titer cytoplasmic ANCA immunostaining pattern and negative anti-proteinase-3 antibody. Joint Bone Spine 2010 Nov 18.
30. Hagen E.C., Daha M.R., Hermans J., Andrassy K., Csernok E., Gaskin G., et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998, 53(3):743-753.
31. Hoffman G.S., Kerr G.S., Leavitt R.Y., Hallahan C.W., Lebovics R.S., Travis W.D., et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992, 116(6):488-498.
32. Barksdale S.K., Hallahan C.W., Kerr G.S., Fauci A.S., Stern J.B., Travis W.D. Cutaneous pathology in Wegener's granulomatosis. A clinicopathologic study of 75 biopsies in 46 patients. Am J Surg Pathol 1995, 19(2):161-172.
33. Bakthavachalam S., Driver M.S., Cox C., Spiegel J.H., Grundfast K.M., Merkel P.A. Hearing loss in Wegener's granulomatosis. Otol Neurotol 2004, 25(5):833-837.
34. Lee S.S., Tang S.H., Sun G.H., Yu C.P., Jin J.S., Chang S.Y. Limited Wegener's granulomatosis of the epididymis and testis. Asian J Androl 2006, 8(6):737-739.
35. Balint G.P., Balint P.V. Felty's syndrome. Best Pract Res Clin Rheumatol 2004, 18(5):631-645.
36. Jani A.L., Hamilos D. Bloody diarrhea, fever, and pancytopenia in a patient with active ulcerative colitis. Ann Allergy Asthma Immunol 2003, 90(4):383-388.
37. Finucane F.M., O'Connell J., Kinsley B.T. Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy. Ir J Med Sci 2008, 177(1):69-71.
38. Rustagi P.K., Currie M.S., Logue G.L. Activation of human complement by immunoglobulin G antigranulocyte antibody. J Clin Invest 1982, 70(6):1137-1147.
39. Hadley A.G., Holburn A.M., Bunch C., Chapel H. Anti-granulocyte opsonic activity and autoimmune neutropenia. Br J Haematol 1986, 63(3):581-589.
40. Muller Kobold A.C., Kallenberg C.G., Tervaert J.W. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis. Br J Rheumatol 1998, 37(8):901-907.
41. Csernok E., Ernst M., Schmitt W., Bainton D.F., Gross W.L. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 1994, 95(2):244-250.
42. Gilligan H.M., Bredy B., Brady H.R., Hebert M.J., Slayter H.S., Xu Y., et al. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 1996, 184(6):2231-2241.
43. Xiao H., Heeringa P., Hu P., Liu Z., Zhao M., Aratani Y., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002, 110(7):955-963.
44. Falk R.J., Hoffman G.S. Controversies in small vessel vasculitis---comparing the rheumatology and nephrology views. Curr Opin Rheumatol 2007, 19(1):1-9.
45. Xiao H., Heeringa P., Liu Z., Huugen D., Hu P., Maeda N., et al. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 2005, 167(1):39-45.